Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ubx1325
2. Schembl22236914
3. Hy-150069
4. Cs-0572519
| Molecular Weight | 1159.7 g/mol |
|---|---|
| Molecular Formula | C53H59ClF3N6O10PS3 |
| XLogP3 | 7.6 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 19 |
| Rotatable Bond Count | 20 |
| Exact Mass | 1158.2833048 g/mol |
| Monoisotopic Mass | 1158.2833048 g/mol |
| Topological Polar Surface Area | 253 Ų |
| Heavy Atom Count | 77 |
| Formal Charge | 0 |
| Complexity | 2160 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
98
PharmaCompass offers a list of UBX1325 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right UBX1325 manufacturer or UBX1325 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred UBX1325 manufacturer or UBX1325 supplier.
PharmaCompass also assists you with knowing the UBX1325 API Price utilized in the formulation of products. UBX1325 API Price is not always fixed or binding as the UBX1325 Price is obtained through a variety of data sources. The UBX1325 Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Foselutoclax manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Foselutoclax, including repackagers and relabelers. The FDA regulates Foselutoclax manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Foselutoclax API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Foselutoclax supplier is an individual or a company that provides Foselutoclax active pharmaceutical ingredient (API) or Foselutoclax finished formulations upon request. The Foselutoclax suppliers may include Foselutoclax API manufacturers, exporters, distributors and traders.
Foselutoclax Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Foselutoclax GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Foselutoclax GMP manufacturer or Foselutoclax GMP API supplier for your needs.
A Foselutoclax CoA (Certificate of Analysis) is a formal document that attests to Foselutoclax's compliance with Foselutoclax specifications and serves as a tool for batch-level quality control.
Foselutoclax CoA mostly includes findings from lab analyses of a specific batch. For each Foselutoclax CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Foselutoclax may be tested according to a variety of international standards, such as European Pharmacopoeia (Foselutoclax EP), Foselutoclax JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Foselutoclax USP).
